• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Heartburn, Defrothicants, GERD
    44 Drugs classified under this therapeutic system

    All the Therapeutic System Drugs

    Filter by letter: ALL A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    not in the basket chart
    Multiple ingredients

    Nicotinic Acid 0.2% w/v, Pepsin 0.6% w/v, Sodium Glycerophosphate 0.8% w/v.
    ORAL DROPS: 40 ml. Child: 20-40 drops
    aft. meals; Inf: 5 drops bef. and aft. ea.
    Gastric indigest., gastroenterit.,
    meteorism, chron. constipat., vomit.,

    full basket chart

    Antacid, Calcium Supplements. Calcium Carbonate 600 mg.
    TABS: 60. As antacid: 1-2 tabs. when
    Calc. supplem.: 2 tabs. 1-3 x dly. 1-1.5
    hrs. after meals Antacid, calcium defic.
    Hyperacid., heartburn, gastrit., pept. ulc,
    calc. supplement.

    full basket chart
    Multiple ingredients

    Adsorbant, Antiflatulent. Charcoal 140 mg, Simethicone 45 mg.
    CAPS: 48 (24 blue; 24 pink). 1 blue cap
    (gastro-sol.) and 1 pink (gastro-resist.) X
    3 dly. Bef. Meals.
    Anti-flatulent, for symptomatic
    treatment of stomach ache resulting
    from accumulation of gas, relief of
    sensation of fullness, meteorism,
    bloating and flatulence.
    C/I: Known hypersens.

    Controloc 20
    not in the basket chart
    Controloc 20

    PPI. Pantoprazole 20 mg.
    E.C. TABS: 30. Adult. & adolesc. 12 yrs. of
    age and above: Reflux dis. and assoc.
    symp. (e.g. heartburn, acid
    regurgitation, pain on swallowi.)-
    20mg×1/d. Symp. relief is gener.
    accompl. within 2-4 wks. If this is not
    suffic., symp. relief will normal. be
    achieved within a further 4 wks. When
    symp. relief has been achieved,
    reoccurring symp. can be control. using
    an on-demand regimen of 20mg×1/d,
    taking one tab. when requir.
    Long-term manag.& preven. of relapse
    in reflux esophag.: Mainten. dose- is 20
    mg×1/d is recomm., incr. to 40 mg ×1/d
    if a relapse occurs.After heal. of the
    relapse the dose can be reduced again
    to 20 mg.
    Adults: Preven. of gastroduod. ulc.
    induced by NSAIDs in pts. at risk with a
    need for contin. NSAID tmt.:
    Tmt. of reflux esophagitis & assoc. symp.
    (e.g. heartburn, acid regurgitation, pain
    on swallow.). For long-term manag. &
    prevent. of relapse in reflux esophagitis.
    Preven. of gastroduodenal ulc. induced
    by NSAIDs in pts. at risk with a need for
    continuous NSAIDs tmt.
    C/I: Hypersens., subst. benzimidazoles. Comb. ther. for the eradication of H. pylori in pts. with renal impair. or severe hep. impair.

    Controloc 40
    not in the basket chart
    Controloc 40

    PPI. Pantoprazole 40 mg.
    E.C. TABS: 14, 28. Tmt. mod-severe
    GERD: Adults/adolesc. 12 yrs and
    above: 1 tab x dly. Erad. H. pylori in
    comb. with 2 approp. antibiotics:
    Adults: Depend. On resist. pattern: a) 2
    x dly: 1 x 40 mg +1,000 mg amoxillin +
    500 mg clarithromycin; b) 2 x dly: 1 x
    40 mg + 500 mg metronidazole + 500
    mg clarithromycin; c) 2 x dly: 1 x 40 mg
    + 1,000 mg amoxicillin + 500 mg
    metronidazole. If comb. ther. not an
    option: Monother. as follows: Tmt.
    gastric/duod. ulc: 1 tab dly.
    Zollinger-Ellison syndr. + other
    hypersecret. conds: Long-term
    manage: Initial: 80 mg dly. Can titrate
    up/ down as reqd. Doses above 80 mg
    dly to be div. into 2 doses.
    Pts. with hep. impair.: dly. dose of 20
    mg exceed. in pts. with sev. hep.
    impair, must not be used in comb. tmt.
    For eradic. H. pylori in pts. with moder.
    – sev. hep. dysfunc. since curren. no
    data are availab. on the effic. & safety
    of Pantoprazole in comb. tmt. of these
    Short term tmt. of acute duod. ulcer,
    acute gastric ulcer, mod./sev. reflux
    esophagi., eradic. of H. pylori in comb.
    With clarithromycin and amoxycillin
    orclarithromycin and metronidazole or
    amoxicillin and metronidazole in cases of
    duoden. ulcer & gastric ulcer with the
    object. of reduc. of duod./gastr.ulc.
    caused by this microorganism, Zollinger
    Ellison Syndr.
    C/I: Hypersens., subst. benzimidazoles .
    Comb. ther. for the eradication of H.
    pylori in pts. with renal impair. or severe
    hep. impair..

    Controloc I.V.
    not in the basket chart
    Controloc I.V.

    PPI. Pantoprazole (as sodium) 40 mg/vial.
    VIAL: 1. Duodenal ulcer, gastric ulc., moderate and severe reflux oesophagitis: 40 mg (1 vial) ×1/d.
    Zollinger-Ellison-Syndr.: For the long-term manag. of Zollinger-Ellison-Syndr. pts. should start their tmt. with a dly. dose of 80 mg. Thereafter, the dose can be titrated up or down as needed using measurements of gastric acid secret. to guide. With doses above 80 mg dly., the dose should be divided and given twice dly. A temporary incr. of the dose above 160 mg  is possible but should not be applied longer than requir. for adequate. acid control.
    In case a rapid acid control is requir, a start. dose of 80 mg×2/d. is suffic. to manage a decrease of acid output into the target range (<10 mEq/h) within 1h in the majority of pts.
    Duodenal ulcer. Gastric ulcer. Moderate and severe reflux oesophagitis. Zollinger-Ellison-Syndrome.
    C/I: Hypersens. to the active subst., substitut. benzimidazoles and any of the excipients.

    Other therapeutic systems under Alimentary System